Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure
通过气溶胶暴露评估小雪茄和水烟气溶胶对肺上皮和心肌细胞的毒性特性
基本信息
- 批准号:9976518
- 负责人:
- 金额:$ 63.86万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2018
- 资助国家:美国
- 起止时间:2018-09-20 至 2022-06-30
- 项目状态:已结题
- 来源:
- 关键词:AddressAerosolsAffectAgeAldehydesAortic AneurysmAromatic Polycyclic HydrocarbonsBiological AssayBiological MarkersBloodCarcinogensCardiacCardiac MyoblastsCardiopulmonaryCardiovascular systemCell DeathCell LineCellsCharcoalChemicalsChronicChronic Obstructive Airway DiseaseCigar SmokingCigaretteComet AssayComplexCoronary arteryCoronary heart diseaseCotinineCoupledDNA AdductsDNA DamageDNA strand breakDataDevelopmentDiseaseDoseEndothelial CellsEpithelialEpithelial CellsEpitheliumExposure toGasesGene ExpressionGenerationsGrowthHazardous ChemicalsHealthHeritabilityHumanImmuneImmune responseImmune signalingIn VitroInflammationKentuckyLinkLipid PeroxidationLiteratureLungMalignant NeoplasmsMalignant neoplasm of lungMeasuresModelingMolecularMucous body substanceNeutral RedNicotineNitrosaminesOutcomeOxidative StressParticulate MatterPathway interactionsPharmacodynamicsPhysiologicalPoliciesPropertyPulmonary EmphysemaPulmonary Heart DiseaseReactive Oxygen SpeciesReportingResearchRiskSignal TransductionSmokingStandardizationSystemThiobarbituric Acid Reactive SubstancesThymidine KinaseTissuesTobaccoTobacco smokeToxic effectWorkairway epitheliumbronchial epitheliumchemical propertycigarette smokecigarilloscomparativecytokinecytotoxiccytotoxicitydesignepidemiology studyevidence baseexperienceexposed human populationgenotoxicityhazardhookahhuman modelimmunoregulationin vitro Modelinflammatory milieuinsightlung developmentparticlephysical propertypredictive toolsrespiratoryresponsesmoke inhalationstem cellstobacco exposuretobacco productstoxicanttranscriptometranscriptome sequencingtreatment responseuptakewhole genomeyoung adult
项目摘要
Project Summary
Nearly 16% of US young adults ages 18–24 report smoking cigars and a recent review documents
growing evidence linking this product to lung cancer, coronary heart disease, aortic aneurysm and COPD.
Similarly, epidemiological studies link waterpipe tobacco to these same diseases. To date, there are few
studies characterizing these tobacco aerosols with respect to toxicant chemicals, and limited information
regarding effects on target cells with respect to cytotoxicity, genotoxicity, inflammation, and immune
responses. Importantly, no comparative dose response studies to cigarettes have been conducted to study
these endpoints, a research gap that is imperative to address for providing pharmacodynamic outcomes for
these addictive nicotine-containing products. Our research will allow for establishment of strong evidence-
based policies to inform the public of their hazardous properties. The specific aims and research strategy
derive from these research gaps and address two of the scientific domains in the RFA, toxicity and health
effects. As mandated by the FDA, the studies are not mechanistic, but are designed to compare responses
and effects at the cellular level across tobacco products (cigarettes, cigarillos, and hookah). The central
hypothesis of this project is that cigarillo and hookah tobacco products will show significantly greater toxicant
properties and predicted health effects when compared to cigarettes. Building on more than two decades of
experience in characterizing the physical and chemical properties of complex aerosols, Aim 1 will provide the
most comprehensive characterization to date for hazardous chemicals linked to cancer and cardiopulmonary
diseases in aerosols from eight common hookah tobacco products. The extensive dose response
characterization of the TPM generated from aerosols of these products using standardized cytotoxicity,
mutagenicity, and genotoxicity assays will also provide key insight regarding the potency of these products for
causing toxicity and harm relative to our studies just completed for cigarettes and cigarillos. Through a battery
of short-term assays and biomarkers (cytokines, DNA adducts), Aim 2 will critically evaluate complete and
fractionated (particles and gas only) aerosols generated from cigarettes, cigarillos, and hookah products in
lung epithelial cells, cardiac cells, and endothelial cells. A cumulative hazard score for each product will be
derived. Aim 3 focuses on adaptive responses of lung epithelial cells in response to treatment of cells for 4-wk
with complete aerosols from one each of these tobacco products. Outcomes from results will include changes
in cytokine levels and pathway alterations that may impact immune response, signaling, invasion, and growth.
These studies should inform generalized responses of the large and small airway epithelium that could
demonstrate a pro-inflammatory environment and/or altered immune signaling documented in the literature to
be associated with mucous hypersecretion and/or emphysema.
项目摘要
我们近16%的年轻人18-24岁的年轻人报告抽雪茄和最近的评论文件
越来越多的证据将该产品与肺癌,冠心病,主动脉瘤和COPD联系起来。
同样,流行病学研究将水烟烟草与这些相同的疾病联系起来。迄今为止,很少
这些有关毒素化学物质和信息有限的研究表征了这些烟草气溶胶
关于细胞毒性,遗传毒性,炎症和免疫的影响的影响
回答。重要的是,尚未对香烟进行比较剂量反应研究研究
这些终点,这是一个研究差距,必须解决为提供药效结果的结果
这些其他含尼古丁的产品。我们的研究将允许建立强有力的证据 -
基于政策,以告知公众他们的危险财产。具体目的和研究策略
来自这些研究差距,并解决RFA,毒性和健康中的两个科学领域
效果。根据FDA的要求,研究不是机械的,而是旨在比较响应
以及烟草产品(香烟,雪茄和水烟)的细胞水平的影响。中央
该项目的假设是雪茄和水烟烟草产品将显示出更大的毒性
与香烟相比,特性和预测的健康影响。建立在二十多年的
在表征复杂气溶胶的物理和化学特性方面的经验,AIM 1将提供
迄今为止与癌症和心肺有关的有害化学物质的最全面的特征
来自八种常见水烟烟草产品的气溶胶中的疾病。广泛的剂量反应
使用标准化的细胞毒性,从这些产品的气溶胶产生的TPM表征,
诱变性和遗传毒性测定也将提供有关这些产品效力的关键见解
相对于我们的研究造成毒性和伤害,刚刚完成了香烟和雪茄。通过电池
在短期评估和生物标志物(细胞因子,DNA加合物)中,AIM 2将严格评估完整和
用香烟,香烟和水烟产物产生的分离(仅颗粒和气体)在
肺上皮细胞,心脏细胞和内皮细胞。每种产品的累积危险分数将是
衍生的。 AIM 3的重点是肺上皮细胞的适应性反应,以应对4-WK细胞的治疗
这些烟草产品中的每种都有完整的气溶胶。结果的结果将包括更改
在细胞因子水平和途径改变中,可能会影响免疫反应,信号传导,侵袭和生长。
这些研究应告知大型和小气道上皮的广义反应
演示文献中记录的促炎环境和/或改变的免疫信号传导
与粘液过度分泌和/或肺气肿有关。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Steven A Belinsky其他文献
Early menopause and hormone therapy as determinants for lung health outcomes: a secondary analysis using the PLCO trial.
早期绝经和激素治疗作为肺部健康结果的决定因素:使用 PLCO 试验的二次分析。
- DOI:
- 发表时间:
2024 - 期刊:
- 影响因子:10
- 作者:
Xiaochun Gai;Yue Feng;Tessa M Flores;Huining Kang;Hui Yu;Kimberly K Leslie;Yiliang Zhu;Jennifer A Doherty;Yan Guo;Steven A Belinsky;Linda S Cook;Shuguang Leng - 通讯作者:
Shuguang Leng
Steven A Belinsky的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Steven A Belinsky', 18)}}的其他基金
Aerosolized Epigenetic Therapy for Metastatic Lung Cancer
雾化表观遗传疗法治疗转移性肺癌
- 批准号:
10760630 - 财政年份:2023
- 资助金额:
$ 63.86万 - 项目类别:
Assessing Toxicant Properties and Health Effects of Cigarillo and Hookah Tobacco Aerosols in Rats
评估小雪茄和水烟气溶胶对大鼠的毒性特性和健康影响
- 批准号:
10413991 - 财政年份:2020
- 资助金额:
$ 63.86万 - 项目类别:
DNA Repair Capacity Assays for Lung Disease Risk Assessment
用于肺部疾病风险评估的 DNA 修复能力测定
- 批准号:
10470762 - 财政年份:2018
- 资助金额:
$ 63.86万 - 项目类别:
Assessing Toxicant Properties of Cigarillo and Hookah Aerosols in Lung Epithelial and Cardiac Cells Through Aerosol Exposure
通过气溶胶暴露评估小雪茄和水烟气溶胶对肺上皮和心肌细胞的毒性特性
- 批准号:
9788459 - 财政年份:2018
- 资助金额:
$ 63.86万 - 项目类别:
DNA Repair Capacity Assays for Lung Disease Risk Assessment
用于肺部疾病风险评估的 DNA 修复能力测定
- 批准号:
10296957 - 财政年份:2018
- 资助金额:
$ 63.86万 - 项目类别:
DNA Repair Capacity Assays for Lung Disease Risk Assessment
用于肺部疾病风险评估的 DNA 修复能力测定
- 批准号:
9768991 - 财政年份:2018
- 资助金额:
$ 63.86万 - 项目类别:
Deposition Profile and Toxicology of E-Cigarettes in the Oral Epithelium
电子烟在口腔上皮细胞中的沉积概况和毒理学
- 批准号:
9117092 - 财政年份:2016
- 资助金额:
$ 63.86万 - 项目类别:
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
吸入 Vidaza 用于靶向表观遗传肺癌治疗
- 批准号:
10208793 - 财政年份:2016
- 资助金额:
$ 63.86万 - 项目类别:
Inhaled Delivery of Vidaza for Targeted Epigenetic Lung Cancer Therapy
吸入 Vidaza 用于靶向表观遗传肺癌治疗
- 批准号:
10296534 - 财政年份:2016
- 资助金额:
$ 63.86万 - 项目类别:
Histone Methyltransferases as a Target for Lung Cancer Prevention
组蛋白甲基转移酶作为肺癌预防的靶点
- 批准号:
8856526 - 财政年份:2014
- 资助金额:
$ 63.86万 - 项目类别:
相似国自然基金
二次有机气溶胶理化性质对其冰核性能的影响
- 批准号:42375069
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
西北不同生态系统下气溶胶对边界层辐射平衡的影响及模拟研究
- 批准号:42375085
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
玛纳斯河流域上游吸收性气溶胶来源及其对积雪消融的影响研究
- 批准号:42307523
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
非球形粒子对气溶胶微物理特性反演与辐射效应评估准确性的影响研究
- 批准号:42305082
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
人为气溶胶和温室气体对全球热带气旋生成频数及分布影响差异机理研究
- 批准号:42375034
- 批准年份:2023
- 资助金额:50.00 万元
- 项目类别:面上项目
相似海外基金
Project 1: Translational Studies on Temperature and Solvent Effects on Electronic Cigarette-Derived Oxidants
项目1:温度和溶剂对电子烟氧化剂影响的转化研究
- 批准号:
10665896 - 财政年份:2023
- 资助金额:
$ 63.86万 - 项目类别:
Penn State TCORS: Tobacco Product Composition Effects on Toxicity and Addiction
宾夕法尼亚州立大学 TCORS:烟草产品成分对毒性和成瘾性的影响
- 批准号:
10665895 - 财政年份:2023
- 资助金额:
$ 63.86万 - 项目类别:
Mitigation of ventilation-based resuspension and spread of airborne viruses in nosocomial and healthcare settings
减轻医院和医疗机构中基于通气的空气传播病毒的再悬浮和传播
- 批准号:
10668064 - 财政年份:2023
- 资助金额:
$ 63.86万 - 项目类别:
The impact of a neonicotinoid pesticide on neural functions underlying learning and memory
新烟碱类农药对学习和记忆神经功能的影响
- 批准号:
10646631 - 财政年份:2023
- 资助金额:
$ 63.86万 - 项目类别:
Role of Type I and III Interferons in Shaping Influenza A Virus Dynamics Within and Between Hosts
I 型和 III 型干扰素在塑造甲型流感病毒宿主内部和之间动态中的作用
- 批准号:
10681893 - 财政年份:2023
- 资助金额:
$ 63.86万 - 项目类别: